Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
World Journal of Gastroenterology|August 26, 2017
Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitisTamas Tornai, Eszter Palyu, Zsuzsanna Vitalis, et al.The Pediatric Infectious Disease Journal|February 27, 2014
Helicobacter pylori Infection in European children with gastro-duodenal ulcers and erosionsPatrick Bontems, Nicolas Kalach, Jean Vanderpas, et al.Gut|May 14, 2014
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committeeFrank M Ruemmele, Jeffrey S Hyams, Anthony Otley, et al.Inflammatory Bowel Diseases|January 26, 2012
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's diseaseRon Shaoul, Marlgozata Sladek, Dan Turner, et al.The American Journal of Gastroenterology|January 12, 2012
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009Peter Laszlo Lakatos, Petra Anna Golovics, Gyula David, et al.Inflammatory Bowel Diseases|November 6, 2019
Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHANMassimo Martinelli, Francesca Paola Giugliano, Caterina Strisciuglio, et al.Pediatric Research|August 25, 2022
Prediction of thiopurine failure in pediatric Crohn's disease: pediatric IBD Porto group of ESPGHANTereza Lerchova, Ondrej Hradsky, Michal Kulich, et al.Inflammatory Bowel Diseases|January 7, 2014
Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) studyArie Levine, Dan Turner, Tamar Pfeffer Gik, et al.Plos One|October 2, 2010
Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?Maria Papp, Gary L Norman, Zsuzsanna Vitalis, et al.Inflammatory Bowel Diseases|October 31, 2008
Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohortPeter Laszlo Lakatos, Istvan Altorjay, Tamas Szamosi, et al.Pageof 9